Skip to main content

Advertisement

SpringerLink
Log in

Comparison of modern marker proteins in serum and synovial fluid in patients with advanced osteoarthrosis and rheumatoid arthritis

  • Original Article
  • Published:
Rheumatology International Aims and scope Submit manuscript

Abstract

Numerous studies have focused on the significance of modern marker proteins in the synovial fluid of the knee joint and in the serum both, for osteoarthritis (OA) and rheumatoid arthritis (RA). The relationship between the serum concentrations and the concentrations in the synovial fluid is still unclear. Synovial fluid and serum samples were obtained from 13 patients with advanced OA and from 8 patients with severe RA and concentrations of MMP-1, MMP-3, MMP-13, TIMP-1, COMP and MIA/CD-RAP were determined. All values were normalized against the total protein concentrations. Serum concentrations of MMP-13 in the RA-group were statistically higher than the synovial values (P<0.05). MMP-13 was the only marker protein that revealed distinct higher levels in the serum than in the synovial fluid. The study design allows only conclusions about advanced stages of RA and OA. Longitudinal investigations may provide further information about the value of MMP-13 as a potential marker to monitor the course of RA and OA.

This is a preview of subscription content, log in via an institution to check access.

Access this article

Log in via an institution

Price excludes VAT (USA)
Tax calculation will be finalised during checkout.

Instant access to the full article PDF.

Institutional subscriptions

Fig. 1
Fig. 2
Fig. 3
Fig. 4

Similar content being viewed by others

References

  1. Yoshihara Y, Nakamura H, Obata K, Yamada H, Hayakawa T (2000) Matrix metalloproteinases and tissue inhibitors of metalloproteinases in synovial fluids from patients with rheumatoid arthritis or osteoarthritis. Ann Rheum Dis 59:455–461

    Article  PubMed  CAS  Google Scholar 

  2. Firestein GS (1996) Etiology and pathogenesis of rheumatoid arthritis. In: Kelly WN, Harris ED Jr, Ruddy S, Sledge CB (eds) The textbook of rheumatology, 5th edn. Saunders, Philadelphia, pp 851–897

    Google Scholar 

  3. Nagase H, Okada Y (1995) Proteinases and matrix degradation. In: Kelly WN, Harris ED Jr, Ruddy S, Sledge CB (eds) The textbook of rheumatology, 5th edn. Saunders, Philadelphia, pp 323–341

    Google Scholar 

  4. Nagase H, Woessner JF Jr (1993) Role of endogenous proteinases in the degradation of cartilage matrix. In: Woessner JF Jr, Howell DS (eds) Joint cartilage degradation. Marcel Dekker, New York, pp 159–185

    Google Scholar 

  5. Greene J, Wang M, Liu YE, Raymond LA, Rosen C, Shi YE (1996) Molecular cloning and characterization of human tissue inhibitor of metalloproteinase 4. J Biol Chem 271:30375–30380

    Article  PubMed  CAS  Google Scholar 

  6. Nagase H (1997) Activation mechanisms of matrix metalloproteinases. Biol Chem 378:151–160

    PubMed  CAS  Google Scholar 

  7. Uria JA, Ferrando AA, Velasco G, Freije JMP, Lopez-Otin C (1994) Structure and expression in breast tumors of human TIMP-3, a new member of the metalloproteinase inhibitor family. Cancer Res 54:2091–2094

    PubMed  CAS  Google Scholar 

  8. Neidel J, Schulze M, Sova L, Lindschau J (1996) Practical significance of cytokine determination in joint fluid in patients with arthroses or rheumatoid arthritis. Z Orthop Ihre Grenzgeb 134:381–385

    Article  PubMed  CAS  Google Scholar 

  9. MacNaul KL, Chartrain N, Lark M, Tocci MJ, Hutchinson NI (1990) Discoordinate expression of stromelysin, collagenase and tissue inhibitor of metalloproteinases-1 in rheumatoid human synovial fibroblasts. Synergetic effects of interleukin-1 and tumor necrosis factor-alpha on stromelysin expression. J Biol Chem 265:17238–17245

    PubMed  CAS  Google Scholar 

  10. Martell Pelletier J, McCollum R, Fujimoto N, Obata K, Cloutier JM, Pelletier JP (1994) Excess of metalloproteases over tissue inhibitor of metalloprotease may contribute to cartilage degradation in osteoarthrosis and rheumatoid arthritis. Lab Invest 70:807–815

    Google Scholar 

  11. Mauviel A (1993) Cytokine regulation of metalloproteinase gene expression. J Cell Biochem 53:288–295

    Article  PubMed  CAS  Google Scholar 

  12. Clark IM, Powell LK, Ramsey S, Hazleman BL, Cawston TE (1993) The measurement of collagenase, tissue inhibitor of metalloproteinases (TIMP) and collagenase-TIMP complex in synovial fluids from patients with osteoarthritis and rheumatoid arthritis. Arthritis Rheum 36:372–379

    Article  PubMed  CAS  Google Scholar 

  13. Shinmei M, Kobayashi T, Yoshihara Y, Samura A (1995) Significance of the levels of carboxy terminal type II procollagen peptide, chondroitin sulfate isomers, tissue inhibitor of metalloproteinases, and metalloproteinases in osteoarthritis joint fluid. J Rheumatol Suppl 43:78–81

    PubMed  CAS  Google Scholar 

  14. Yoshihara Y, Obata K, Fujimoto N, Yamashita K, Hayakawa T, Shimmei M (1995) Increased levels of stromelysin-1 and tissue inhibitor of metalloproteinases-1 in sera from patients with rheumatoid arthritis. Arthritis Rheum 38:969–975

    Article  PubMed  CAS  Google Scholar 

  15. Saxne T, Heinegard D (1992) Cartilage oligomeric matrix protein: a novel marker of cartilage turnover detectable in synovial fluid and blood. Br J Rheumatol 31:583–591

    Article  PubMed  CAS  Google Scholar 

  16. Marti C, Neidhart M, Gerber T, Hauser N, Michel BA, Hauselmann HJ (1999) Cartilage oligomeric matrix protein (COMP): the role of a non-collagen cartilage matrix protein as a marker of disease activity and joint destruction in patients with rheumatoid arthritis and osteoarthritis. Z Rheumatol 58:79–87

    Article  PubMed  CAS  Google Scholar 

  17. Vilim V, Olejarova M, Machacek S, Gatterova J, Kraus VB, Pavelka K (2002) Serum levels of cartilage oligomeric matrix protein (COMP) correlate with radiographic progression of knee osteoarthritis. Osteoarthritis Cartilage 10:707–713

    Article  PubMed  CAS  Google Scholar 

  18. Bosserhoff AK, Buettner R (2002) Expression, function and clinical relevance of MIA (melanoma inhibiting activity). Histol Histopathol 17:289–300

    PubMed  CAS  Google Scholar 

  19. Bosserhoff AK, Kaufmann M, Kaluza B, Bartke I, Zirngibl H, Hein R, Stolz W., Buettner R (1997) Melanoma-inhibiting activity, a novel serum marker for progression of malignant melanoma. Cancer Res 57:3149–3153

    PubMed  CAS  Google Scholar 

  20. Wagner V, Rudi J, Naher H, Stremmel W (2000) Seropositivity for MIA and S100 in patients with gastrointestinal carcinomas. Med Oncol 17:35–38

    Article  PubMed  CAS  Google Scholar 

  21. Müller-Ladner U, Bosserhoff AK, Dreher K, Hein R, Neidhart M, Gay S, Scholmerich J, Buettner R, Lang B (1999) MIA (melanoma inhibitory activity): a potentional serum marker for rheumatoid arthritis. Rheumatology 38:148–154

    Article  PubMed  Google Scholar 

  22. Schmidt-Rohlfing B, Schneider U, Thomsen M, Bosserhoff AK (2002) Correlation of a novel matrix protein with the degree of cartilage degradation. Rheumatol Int 22:165–169

    Article  PubMed  Google Scholar 

  23. Lohmander LS, Dahlberg L, Ryd L, Heinegard D (1989) Increased levels of proteoglycan fragments in knee joint fluid after injury. Arthritis Rheum 32:1434–1442

    Article  PubMed  CAS  Google Scholar 

  24. Schmidt-Rohlfing B, Gavenis K, Kippels M, Schneider U (2002) New potential markers for cartilage degradation of the knee joint. Scand J Rheumatol 31:151–157

    Article  PubMed  Google Scholar 

  25. Väätäinen U, Lohmander LS, Thonar E, Hongisto T, Agren U, Rönkkö S, Jaroma H, Kosma VM, Tammi M, Kiviranta I (1998) Markers of cartilage and synovial metabolism in joint fluid and serum of patients with chondromalacia of the patella. Osteoarthritis Cartilage 6:115–124

    Article  PubMed  Google Scholar 

  26. Aigner T, Zien A, Gehrsitz A, Gebhard PM, McKenna L (2001) Anabolic and catabolic gene expression pattern analysis in normal versus osteoarthritic cartilage using complementary DNA-array technology. Arthritis Rheum 44:2777–2789

    Article  PubMed  CAS  Google Scholar 

  27. Bau B, Gebhard PM, Haag J, Knorr T, Bartnik E, Aigner T (2002) Relative messenger RNA expression profiling of collagenases and aggrecanases in human articular chondrocytes in vivo and in vitro. Arthritis Rheum 46:2648–2657

    Article  PubMed  CAS  Google Scholar 

  28. Bluteau G, Conrozier T, Mathieu P, Vignon E, Herbage D, Mallein-Gerin F (2001) Matrix metalloproteinase-1, −3, −13 and aggrecanase-1 and −2 are differentially expressed in experimental osteoarthritis. Biochim Biophys Acta 1526:147–158

    PubMed  CAS  Google Scholar 

  29. Cunnane G, Fitzgerald O, Beeton C, Cawston TE, Bresnihan B (2001) Early joint erosions and serum levels of matrix metalloproteinase 1, matrix metalloproteinase 3, and tissue inhibitor of metalloproteinase 1 in rheumatoid arthritis. Arthritis Rheum 44:2263–2274

    Article  PubMed  CAS  Google Scholar 

  30. Ishiguro N, Ito T, Oguchi T, Kojima T, Iwata H, Ionescu M, Poole AR (2001) Relationships of matrix metalloproteinases and their inhibitors to cartilage proteoglycan and collagen turnover and inflammation as revealed by analyses of synovial fluids from patients with rheumatoid arthritis. Arthritis Rheum 44:2503–2511

    Article  PubMed  CAS  Google Scholar 

  31. Klimiuk PA, Sierakowski S, Latosiewicz R, Cylwik B, Skowronski J, Chwiecko J (2002) Serum matrix metalloproteinases and tissue inhibitors of metalloproteinases in different histological variants of rheumatoid synovitis. Rheumatology (Oxford) 41:78–87

    Article  CAS  Google Scholar 

  32. Bramono DS, Richmond JC, Weitzel PP, Kaplan DL, Altman GH (2004) Matrix metalloproteinases and their clinical applications in orthopaedics. Clin Orthop Relat Res 428:272–285

    Article  PubMed  Google Scholar 

  33. Mitchell PG, Magna HA, Reeves LM, Lopresti-Morrow LL, Yocum SA, Rosner PJ, Geohegan KF, Hambor JE (1996) Cloning, expression and type II collagenolytic activity of matrix metalloproteinase-13 from human osteoarthritic cartilage. Clin Invest 97:761–768

    CAS  Google Scholar 

  34. Lindy O, Konttinen YT, Sorsa T, Ding Y, Santavirta S, Ceponis A, Lopez-Otin C (1997) Matrix metalloproteinase 13 (Collagenase 3) in human rheumatoid synovium. Arthritis Rheum 40:1391–1399

    Article  PubMed  CAS  Google Scholar 

  35. Gay S, Gay RE, Koopman WJ (1993) Molecular and cellular mechanisms of joint destruction in rheumatoid arthritis: two cellular mechanisms explain joint destruction. Ann Rheum Dis 52:839–847

    Article  Google Scholar 

  36. Gay S, Gay RE (1989) Cellular basis and oncogene expression of rheumatoid joint destruction. Rheumatol Int 9:105–113

    PubMed  CAS  Google Scholar 

  37. Zvaifler NJ, Tsai V, Alsalameh S, von Kempis J, Firestein G, Lotz M (1997) Pannocytes: distinctive cells found in rheumatoid arthritis cartilage erosions. Am J Pathol 150:1125–1138

    PubMed  CAS  Google Scholar 

Download references

Author information

Authors and Affiliations

  1. Department of Orthopaedic Surgery, Aachen University Hospital, Pauwelsstr. 30, 52074, Aachen, Germany

    S. Andereya, B. Schmidt-Rohlfing, T. Mumme, R. Müller-Rath & U. Schneider

  2. Departement of Orthopaedic Surgery, University of Heidelberg, Heidelberg, Germany

    N. Streich

Authors
  1. S. Andereya
    View author publications

    You can also search for this author in PubMed Google Scholar

  2. N. Streich
    View author publications

    You can also search for this author in PubMed Google Scholar

  3. B. Schmidt-Rohlfing
    View author publications

    You can also search for this author in PubMed Google Scholar

  4. T. Mumme
    View author publications

    You can also search for this author in PubMed Google Scholar

  5. R. Müller-Rath
    View author publications

    You can also search for this author in PubMed Google Scholar

  6. U. Schneider
    View author publications

    You can also search for this author in PubMed Google Scholar

Corresponding author

Correspondence to S. Andereya.

Rights and permissions

Reprints and permissions

About this article

Cite this article

Andereya, S., Streich, N., Schmidt-Rohlfing, B. et al. Comparison of modern marker proteins in serum and synovial fluid in patients with advanced osteoarthrosis and rheumatoid arthritis. Rheumatol Int 26, 432–438 (2006). https://doi.org/10.1007/s00296-005-0006-2

Download citation

  • Received:

  • Accepted:

  • Published:

  • Issue Date:

  • DOI: https://doi.org/10.1007/s00296-005-0006-2

Keywords

Search

Navigation